- Home
- LASE vs NRXP Comparison
LASE vs NRXP Comparison
Compare LASE & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LASE
- NRXP
- Stock Information
- Founded
- LASE 2019
- NRXP 2015
- Country
- LASE United States
- NRXP United States
- Employees
- LASE N/A
- NRXP N/A
- Industry
- LASE Industrial Machinery/Components
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- LASE Industrials
- NRXP Health Care
- Exchange
- LASE Nasdaq
- NRXP Nasdaq
- Market Cap
- LASE 51.8M
- NRXP 32.6M
- IPO Year
- LASE 2022
- NRXP N/A
- Fundamental
- Price
- LASE $3.27
- NRXP $2.94
- Analyst Decision
- LASE
- NRXP Strong Buy
- Analyst Count
- LASE 0
- NRXP 4
- Target Price
- LASE N/A
- NRXP $28.50
- AVG Volume (30 Days)
- LASE 490.1K
- NRXP 189.6K
- Earning Date
- LASE 07-07-2025
- NRXP 08-13-2025
- Dividend Yield
- LASE N/A
- NRXP N/A
- EPS Growth
- LASE N/A
- NRXP N/A
- EPS
- LASE N/A
- NRXP N/A
- Revenue
- LASE $4,962,487.00
- NRXP N/A
- Revenue This Year
- LASE N/A
- NRXP N/A
- Revenue Next Year
- LASE N/A
- NRXP N/A
- P/E Ratio
- LASE N/A
- NRXP N/A
- Revenue Growth
- LASE 23.87
- NRXP N/A
- 52 Week Low
- LASE $1.58
- NRXP $1.10
- 52 Week High
- LASE $19.80
- NRXP $6.01
- Technical
- Relative Strength Index (RSI)
- LASE 58.03
- NRXP 40.46
- Support Level
- LASE $2.90
- NRXP $3.12
- Resistance Level
- LASE $4.31
- NRXP $3.53
- Average True Range (ATR)
- LASE 0.38
- NRXP 0.16
- MACD
- LASE 0.05
- NRXP -0.07
- Stochastic Oscillator
- LASE 43.65
- NRXP 8.62
About LASE Laser Photonics Corporation
Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasives blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, aerospace, machine manufacturing, nuclear maintenance and de-commissioning, and surface coating.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.